Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Total Debt (2017 - 2020)

AC Immune has reported Total Debt over the past 4 years, most recently at $336773.3 for Q3 2020.

  • Quarterly Total Debt fell 47.41% to $336773.3 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $336773.3 through Sep 2020, down 47.41% year-over-year, with the annual reading at $656409.3 for FY2019, 26.11% up from the prior year.
  • Total Debt was $336773.3 for Q3 2020 at AC Immune, up from $333137.6 in the prior quarter.
  • Over five years, Total Debt peaked at $658770.1 in Q4 2019 and troughed at $583.43 in Q2 2019.
  • The 4-year median for Total Debt is $336773.3 (2020), against an average of $388856.3.
  • The largest YoY upside for Total Debt was 57000.32% in 2020 against a maximum downside of 47.41% in 2020.
  • A 4-year view of Total Debt shows it stood at $500708.2 in 2017, then rose by 3.95% to $520504.4 in 2018, then increased by 26.56% to $658770.1 in 2019, then plummeted by 48.88% to $336773.3 in 2020.
  • Per Business Quant, the three most recent readings for ACIU's Total Debt are $336773.3 (Q3 2020), $333137.6 (Q2 2020), and $334966.3 (Q1 2020).